Final Programme 2019

15 WORLD FEDERATION SCIENTIFIC PROGRAMME Thursday, 25 April 2017 RC-01 Research Consortia Symposium 14:00–15:30 Auditorium IV International collaboration on ADHD and substance abuse: New research on ADHD and substance abuse Chairs: C. Crunelle, Belgium G. van de Glind, The Netherlands RC-02-001 International consensus statement on diag- nosis and treatment of ADHD in patients with substance use disorders C. Crunelle, Belgium RC-02-002 Adult ADHD and its association with sub- stance use and substance use disorders in young men M. Mohler-Kuo, Switzerland RC-02-003 Diagnosis of substance use disorders and the severity of substance use disorders in patients with and without ADHD R. Icick, France RC-02-004 Antisocial personality disorder in patients with substance abuse disorders with and without ADHD G. van de Glind, The Netherlands YS-01 Young Scientist‘ Session I 14:00–15:30 Auditorium III Chairs: S. Faraone, USA P. Riederer, Germany YS-01-001 Genes and brain cell types linked with selective neuronal vulnerability in ADHD J. Hess, USA YS-01-002 Genetic liability to ADHD and substance use disorders in individuals with ADHD T. Wimberley, Denmark YS-01-003 Genetic alteration of CADM1 is associated with ADHD during early life: An explora- tory study with genetic, neuroimaging and animal model methods J. Jin, People’s Republic of China YS-01-004 Effects of methylphenidate on sleep in children with ADHD I. Ferreira, Portugal 15:30 – 16:00 Coffee Break RC-02 Research Consortia Symposium 16:00–17:30 Auditorium III EU consortia CoCA and Eat2BeNICE: The influence of food and/or physical activity on the course of ADHD Chairs: M. Ribases, Spain N. Rommelse, The Netherlands RC-03-001 A lifespan perspectives on the genetics of ADHD M. Ribases, Spain RC-03-002 ADHD and obesity: What do genetics tell us and how is the brain involved? N. Roth Mota, The Netherlands RC-03-003 The effect of exercise on ADHD S. Kittel-Schneider, Germany RC-03-004 Food and ADHD on restriction diets, sup- plements, and probiotics N. Rommelse, The Netherlands RC-03 Research Consortia Symposium 16:00–17:30 Room 5 A ADHD and its comorbidity with psychiatric and non- psychiatric disorders across the lifespan (EU Consortium CoCA) Chairs: A. Reif, Germany S. Faraone, USA RC-01-001 Polygenic risk for ADHD and association with outcomes S. Dalsgaard, Denmark RC-01-002 ADHD and comorbidities: Gender differ- ences K. Klungsøyr, Norway RC-01-003 Data mining in prediction models of obe- sity in ADHD S. Faraone, USA RC-01-004 ADHD and comorbidities: Cost analyses A. Reif, Germany HT-06 Hot Topic Symposium 16:00–17:30 Room 5 B Why guidelines give different directions for clinicians on the care and management of ADHD across the life cycle? Chairs: D. Coghill, Australia J. Boavida, Portugal HT-06-001 The CADDRA perspective D. Quinn, Canada